Pathway analysis of coronary atherosclerosis

Physiological Genomics

Volumn 23, Issue 1, 2005, Pages 103-118

  King, Jennifer Y ^a   Ferrara, Rossella ^a   Tabibiazar, Raymond ^a   Spin, Joshua M ^a   Chen, Mary M ^a   Kuchinsky, Allan ^b   Vailaya, Aditya ^b   Kincaid, Robert ^b   Tsalenko, Anya ^b   Deng, David Xing Fei ^b   Connolly, Andrew ^a   Zhang, Peng ^a   Yang, Eugene ^a   Watt, Clifton ^a   Yakhini, Zohar ^b   Ben Dor, Amir ^b   Adler, Annette ^b   Bruhn, Laurakay ^b   Tsao, Philip ^a   Quertermous, Thomas ^a   Ashley, Euan A ^a   more..

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AGILENT LABORATORIES   (United States)

Author keywords

Cardiovascular disease; Coronary arterial disease; Gene expression profiling; Microarray; Networks; Pathways; Systems biology

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE COURSE; DNA HYBRIDIZATION; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE INTERACTION; HEART GRAFT; HUMAN; HUMAN CELL; LANGUAGE; MALE; NUCLEOTIDE SEQUENCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RNA ISOLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TIGHT JUNCTION; UNINDEXED SEQUENCE;

ADULT; AGED; ANIMALS; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; CORONARY ARTERIOSCLEROSIS; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME; HUMANS; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; MODELS, BIOLOGICAL; MODELS, STATISTICAL; MYOCARDIAL ISCHEMIA; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA; SYSTEMS BIOLOGY;

EID: 33645770959     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00101.2005     Document Type: Article

References (57)

1. American Heart Association. Heart Disease and Stroke Statistics-2004 Update. Dallas, TX: American Heart Association, 2003.
2. Armen J and Smith BW. Exercise considerations in coronary artery disease, peripheral vascular disease, and diabetes mellitus. Clin Sports Med 22: viii and 123-133, 2003.
3. Barabasi AL and Oltvai ZN. Network biology: understanding the cell's functional organization. Nat Rev Genet 5: 101-113, 2004.
4. Beckman JA, Creager MA, and Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287: 2570-2581, 2002.
5. Bergmann S, Ihmels J, and Barkai N. Similarities and differences in genome-wide expression data of six organisms. PLoS Biol 2: E9, 2004.
6. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, and Maseri A. Elevated levels of interleukin-6 in unstable angina. Circulation 94: 874-877, 1996.
7. Correia ML and Haynes WG. Leptin, obesity and cardiovascular disease. Curr Opin Nephrol Hypertens 13: 215-223, 2004.
8. Crook M. Type 2 diabetes mellitus: a disease of the innate immune system? An update. Diabet Med 21: 203-207, 2004.
9. Dobrovolskaia MA and Vogel SN. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 4: 903-914, 2002.
10. Eisen MB, Spellman PT, Brown PO, and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863-14868, 1998.
11. Evans A, Van Baal GC, McCarron P, DeLange M, Soerensen TI, De Geus EJ, Kyvik K, Pedersen NL, Spector TD, Andrew T, Patterson C, Whitfield JB, Zhu G, Martin NG, Kaprio J, and Boomsma DI. The genetics of coronary heart disease: the contribution of twin studies. Twin Res 6: 432-441, 2003.
12. Festa A, D'Agostino R Jr, Tracy RP, and Haffner SM. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51: 1131-1137, 2002.
13. Franz WM, Frey N, Muller O, Kubler W, and Katus HA. [A transgenic animal model: new possibilities for cardiovascular research]. Z Kardiol 84, Suppl 4: 17-32, 1995.
14. Ghazalpour A, Doss S, Yang X, Aten J, Toomey EM, Van Nas A, Wang S, Drake TA, and Lusis AJ. Thematic review series: the pathogenesis of atherosclerosis. Toward a biological network for atherosclerosis. J Lipid Res 45: 1793-1805, 2004.
15. Henneke P and Golenbock DT. Innate immune recognition of lipopolysaccharide by endothelial cells. Crit Care Med 30: S207-S213, 2002.
16. Hibbert L, Pflanz S, De Waal Malefyt R, and Kastelein RA. IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J Interferon Cytokine Res 23: 513-522, 2003.
17. Ho M, Yang E, Matcuk G, Deng D, Sampas N, Tsalenko A, Tabibiazar R, Zhang Y, Chen M, Talbi S, Ho YD, Wang J, Tsao PS, Ben-Dor A, Yakhini Z, Bruhn L, and Quertermous T. Identification of endothelial cell genes by combined database mining and microarray analysis. Physiol Genomics 13: 249-262, 2003.
18. Hong Y, de Faire U, Heller DA, McClearn GE, and Pedersen N. Genetic and environmental influences on blood pressure in elderly twins. Hypertension 24: 663-670, 1994.
19. Huber SA, Sakkinen P, Conze D, Hardin N, and Tracy R. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol 19: 2364-2367, 1999.
20. Iliadou A, Lichtenstein P, Morgenstern R, Forsberg L, Svensson R, de Faire U, Martin NG, and Pedersen NL. Repeated blood pressure measurements in a sample of Swedish twins: heritabilities and associations with polymorphisms in the renin-angiotensin-aldosterone system. J Hypertens 20: 1543-1550, 2002.
21. Johnson CD, Balagurunathan Y, Lu KP, Tadesse M, Falahatpisheh MH, Carroll RJ, Dougherty ER, Afshari CA, and Ramos KS. Genomic profiles and predictive biological networks in oxidant-induced atherogenesis. Physiol Genomics 13: 263-275, 2003.
22. Kanehisa M and Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28: 27-30, 2000.
23. Kincaid R, Kleusing D, and Vailaya A. BNS: an LDAP-Based Biomolecule Naming Service. Washington, DC: Objects in Bio- and Chem-Informatics, 2002.
24. Laaksonen DE, Niskanen L, Nyyssonen K, Punnonen K, Tuomainen TP, Valkonen VP, Salonen R, and Salonen JT. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 47: 1403-1410, 2004.
25. Larkin JE, Frank BC, Gaspard RM, Duka I, Gavras H, and Quackenbush J. Cardiac transcriptional response to acute and chronic angiotensin II treatments. Physiol Genomics 18: 152-166, 2004.
26. Libby P. Inflammation in atherosclerosis. Nature 420: 868-874, 2002.
27. Libby P, Ridker PM, and Maseri A. Inflammation and atherosclerosis. Circulation 105: 1135-1143, 2002.
28. Lopes N, Vasudevan SS, Alvarez RJ, Binkley PF, and Goldschmidt PJ. Pathophysiology of plaque instability: insights at the genomic level. Prog Cardiovasc Dis 44: 323-338, 2002.
29. Lu H, Raptis M, Black E, Stan M, Amar S, and Graves DT. Influence of diabetes on the exacerbation of an inflammatory response in cardiovascular tissue. Endocrinology 145: 4934-4939, 2004.
30. Lucas S, Ghilardi N, Li J, and de Sauvage FJ. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc Natl Acad Sci USA 100: 15047-15052, 2003.
31. Marston SB and Smith CW. The thin filaments of smooth muscles. J Muscle Res Cell Motil 6: 669-708, 1985.
32. Mulvihill ER, Jaeger J, Sengupta R, Ruzzo WL, Reimer C, Lukito S, and Schwartz SM. Atherosclerotic plaque smooth muscle cells have a distinct phenotype. Arterioscler Thromb Vasc Biol 24: 1283-1289, 2004.
33. Nordskog BK, Blixt AD, Morgan WT, Fields WR, and Hellmann GM. Matrix-degrading and pro-inflammatory changes in human vascular endothelial cells exposed to cigarette smoke condensate. Cardiovasc Toxicol 3: 101-117, 2003.
34. Ohashi R, Mu H, Yao Q, and Chen C. Cellular and molecular mechanisms of atherosclerosis with mouse models. Trends Cardiovasc Med 14: 187-190, 2004.
35. Peltonen L. GenomEUtwin: a strategy to identify genetic influences on health and disease. Twin Res 6: 354-360, 2003.
36. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27: 813-823, 2004.
37. Pickup JC and Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41: 1241-1248, 1998.
38. Poulter N. Coronary heart disease is a multifactorial disease. Am J Hypertens 12: 92S-95S, 1999.
39. Presbitero P, Zavalloni D, Scatturin M, Marisco F, Pagnotta P, and Boccuzzi G. Procedural and long-term results of sirolimus-eluting stent in patients at high risk for restenosis. Minerva Cardioangiol 52: 189-194, 2004.
40. Romaldini CC, Issler H, Cardoso AL, Diament J, and Forti N. [Risk factors for atherosclerosis in children and adolescents with family history of premature coronary artery disease]. J Pediatr 80: 135-140, 2004.
41. Rosal MC, Ockene JK, Luckmann R, Zapka J, Goins KV, Saperia G, Mason T, and Donnelly G. Coronary heart disease multiple risk factor reduction; providers' perspectives. Am J Prev Med 27: 54-60, 2004.
42. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126, 1999.
43. Rothermel AL, Wang Y, Schechner J, Mook-Kanamori B, Aird WC, Pober JS, Tellides G, and Johnson DR. Endothelial cells present antigens in vivo. BMC Immunol 5: 5, 2004.
44. Rubartelli P, Niccoli L, Alberti A, Giachero C, Ettori F, Missiroli B, Bernardi G, Maiello L, Reimers B, Cernigliaro C, Sardella G, and Bramucci E. Coronary rotational atherectomy in current practice: acute and mid-term results in high- and low-volume centers. Catheter Cardiovasc Interv 61: 463-471, 2004.
45. Schieffer B, Selle T, Hilfiker A, Hilfiker-Kleiner D, Grote K, Tietge UJ, Trautwein C, Luchtefeld M, Schmittkamp C, Heeneman S, Daemen MJ, and Drexler H. Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Circulation 110: 3493-3500, 2004.
46. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, and Heiss G. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353: 1649-1652, 1999.
47. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, and Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13: 2498-2504, 2003.
48. Song L and Schindler C. IL-6 and the acute phase response in murine atherosclerosis. Atherosclerosis 177: 43-51, 2004.
49. Spin JM, Nallamshetty S, Tabibiazar R, Ashley EA, King JY, Chen M, Tsao PS, and Quertermous T. Transcriptional profiling of in vitro smooth muscle cell differentiation identifies specific patterns of gene and pathway activation. Physiol Genomics 19: 292-302, 2004.
50. Stary HC. Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler Thromb Vasc Biol 20: 1177-1178, 2000.
51. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, and Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92: 1355-1374, 1995.
52. Stary HC, Chandler AB, Glagov S, Guyton JR, InsullWJr, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, and Wissler RW. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 89: 2462-2478, 1994.
53. Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, Botstein D, and Altman RB. Missing value estimation methods for DNA microarrays. Bioinformatics 17: 520-525, 2001.
54. Tusher VG, Tibshirani R, and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001.
55. Vailaya A, Bluvas P, Kincaid R, Kuchinsky A, Creech M, and Adler A. An architecture for biological information extraction and representation. Bioinformatics 21: 430-438, 2005.
56. Valentine RJ, Guerra R, Stephan P, Scoggins E, Clagett GP, and Cohen J. Family history is a major determinant of subclinical peripheral arterial disease in young adults. J Vasc Surg 39: 351-356, 2004.
57. Willerson JT and Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 109: II2-II10, 2004.